An investigation into the anticancer properties of black tea using in vivo model

Abstract

Author(s): Asha K., Deepthi Krishna, Geetika M. Patel

A Study of Black Tea's Anticancer Properties Using an In Vivo Model. Black tea contains compounds such as polyphenols, theaflavins, caffeine, L-theanine, and EGCG, which have been linked to potential anticancer properties. These compounds have been shown to prevent the growing of cancer cell and encourage involuntary cell death in laboratory studies. However, more study is required to conclude the exact anticancer properties of black tea in humans. Black tea's anti-carcinogenic qualities stem from its ability to regulate oxidative damage to endogenous antioxidants, mutagens, and biomolecules' antioxidant gene transcription pathways, among other things. Nonetheless, adding black tea to a healthy diet may have overall health benefits. Regular use of black tea, which is high in phytochemicals and may help prevent and treat cancer, has been connected regulation of several molecular targets, including 5-Lipoxygenase, Cyclooxygenase-2, c-Jun N-terminal Kinase, Signal Transducer and Activator of Transcription, Activator Protein 1, and MAPK. Black tea's anti-cancer action is supported in vivo; nevertheless, its impact on human trials is unknown, even if further clinical investigations at the molecular level are required to comprehend this feature.

Share this article